Home
AMGN
AMGN News

Latest Amgen Inc. (AMGN) News on October 15, 2025

Amgen (AMGN) Announces Launch of AmgenNow

Insider Monkey

a day ago

Amgen (AMGN) Announces Launch of AmgenNow

Why Amgen (AMGN) Could Beat Earnings Estimates Again

Zacks

2 days ago

Why Amgen (AMGN) Could Beat Earnings Estimates Again

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention

Insider Monkey

2 days ago

Amgen Repatha Phase 3 Trial Meets Dual Primary Endpoints for Primary Cardiovascular Prevention

Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN)

StockStory

3 days ago

Reflecting On Therapeutics Stocks’ Q2 Earnings: Amgen (NASDAQ:AMGN)

With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing

Simply Wall St.

3 days ago

With 81% ownership, Amgen Inc. (NASDAQ:AMGN) boasts of strong institutional backing

Here's What to Expect From Amgen’s Next Earnings Report

Barchart

5 days ago

Here's What to Expect From Amgen’s Next Earnings Report

What Do Charts Say About the Dow? 3 Favorite Stocks That Could Lead a Year-End Push.

Barrons.com

6 days ago

What Do Charts Say About the Dow? 3 Favorite Stocks That Could Lead a Year-End Push.

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

GlobeNewswire

6 days ago

Bispecific Antibodies Market - Global Forecast 2025-2032, Profiles of Key Players - F. Hoffmann-La Roche, Amgen, Janssen Biotech, Pfizer, AbbVie, Regeneron, MacroGenics, AstraZeneca, Merck, and Genmab

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

Zacks

7 days ago

Is Trending Stock Amgen Inc. (AMGN) a Buy Now?

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

StockStory

7 days ago

2 S&P 500 Stocks to Target This Week and 1 Facing Challenges

Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?

Simply Wall St.

7 days ago

Does Amgen’s Recent 4.7% Surge Signal Room for Growth in 2025?

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%

Zacks

8 days ago

Amgen Unveils New DTC Program, Cuts Cholesterol Drug Price by 60%

/C O R R E C T I O N -- Amgen/

PR Newswire

9 days ago

/C O R R E C T I O N -- Amgen/

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Zacks

9 days ago

Amgen (AMGN) Stock Sinks As Market Gains: Here's Why

Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online

GuruFocus.com

9 days ago

Amgen Slashes Drug Price After Trump Threat--Repatha Now 60% Cheaper Online

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

The Wall Street Journal

9 days ago

Amgen Lowers Cholesterol-Medication Price After Trump Call for Price Cuts

MT Newswires

9 days ago

GoodRx Expands Affordable Access to Cholesterol Drug Repatha

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035

GlobeNewswire

9 days ago

Bullous Pemphigoid Market Analysis and Forecast Report 2025-2035

MT Newswires

9 days ago

Amgen Introduces Direct-to-Patient Access for Repatha in US

Here's Why Amgen (AMGN) is a Strong Value Stock

Zacks

9 days ago

Here's Why Amgen (AMGN) is a Strong Value Stock

4 Reasons to Buy Amgen Stock Right Now

Motley Fool

11 days ago

4 Reasons to Buy Amgen Stock Right Now

Amgen’s Phase III data supports FDA label expansion of Repatha

Clinical Trials Arena

12 days ago

Amgen’s Phase III data supports FDA label expansion of Repatha

Amgen’s Phase III data supports FDA label expansion of Repatha

Pharmaceutical Technology

12 days ago

Amgen’s Phase III data supports FDA label expansion of Repatha

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial

Clinical Trials Arena

12 days ago

Long-term benefit of Amgen’s Repatha in reducing MACE shown in Phase III trial

September in Review: 11 Top Health Press Releases

PR Newswire

12 days ago

September in Review: 11 Top Health Press Releases

Argus Research

13 days ago

Analyst Report: Regeneron Phars, Inc

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise

Simply Wall St.

13 days ago

Amgen (AMGN): Examining Valuation After Recent 6% Share Price Rise

MT Newswires

13 days ago

Amgen Says Dual Primary Endpoints Met in Phase 3 Cardiovascular Events Prevention Trial of Repatha

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Zacks

13 days ago

Why Amgen (AMGN) is a Top Momentum Stock for the Long-Term

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen

StockStory

13 days ago

Stocks making big moves yesterday: ZoomInfo, Dave, Atkore, Saia, and Amgen

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS

PR Newswire

13 days ago

LANDMARK PHASE 3 TRIAL (VESALIUS-CV) MEETS PRIMARY ENDPOINTS IN A CARDIOVASCULAR PRIMARY PREVENTION STUDY OF 12,000 PATIENTS

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done

Investor's Business Daily

13 days ago

Bruce Beutler Unlocked Key Mystery To Disease — And He's Not Done

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer

Motley Fool

13 days ago

2 High-Yield Dividend Growth Stocks to Buy in October and Hold for a Decade or Longer

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs

Insider Monkey

13 days ago

Amgen Inc (AMGN) Ramps Up Manufacturing Capacity in US, Amidst Hefty Tariffs

Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion

Insider Monkey

13 days ago

Amgen (AMGN) Announces $650M Puerto Rico Facility Expansion

Morningstar Research

14 days ago

Analyst Report: Amgen Inc.

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks

Benzinga

14 days ago

Marjorie Taylor Greene Loads Up On Six-Figure Treasury Bill— Diversifies Portfolio With Bitcoin ETF, Tech Stocks

S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown

MT Newswires

14 days ago

S&P 500, Dow Reach New Peaks as Traders Look Past Ongoing Shutdown

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

GlobeNewswire

14 days ago

2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff

Investor's Business Daily

14 days ago

Why Drug Stocks Are Celebrating Trump's 100% Pharmaceutical Tariff

Immatics Appoints Venkat Ramanan as Chief Financial Officer

GlobeNewswire

14 days ago

Immatics Appoints Venkat Ramanan as Chief Financial Officer

MT Newswires

15 days ago

Drug Manufacturers Help Push US Equity Indexes Higher While Government Shutdown Looms

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.

Barrons.com

15 days ago

Pfizer Stock Soars on Trump’s New Drug Pricing Plan. Here’s Why.

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

StockStory

15 days ago

Repligen, BrightSpring Health Services, Danaher, Thermo Fisher, and Amgen Shares Skyrocket, What You Need To Know

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)

Insider Monkey

15 days ago

Bank of America Securities Maintains a Sell Rating on Amgen (AMGN)

Amgen to expand US drug production with $650M investment

Manufacturing Dive

15 days ago

Amgen to expand US drug production with $650M investment

Amgen to invest $650m in US manufacturing network expansion

Pharmaceutical Technology

16 days ago

Amgen to invest $650m in US manufacturing network expansion

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency

Insider Monkey

16 days ago

Amgen Inc.’s (AMGN) and AstraZeneca’s (AZN) Tezspire Receives Positive Recommendation from the EU Medicines Agency

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs

Insider Monkey

17 days ago

Amgen Inc. (AMGN) Invests $650M to Expand Puerto Rico Biologics Facility, Adds 750 Jobs

Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)

Simply Wall St.

18 days ago

Expansion of U.S. Manufacturing and Tezspire Approval Might Change the Case for Investing in Amgen (AMGN)

GLP-1 race evolves as Amgen & weight-loss pills enter the scene

Yahoo Finance Video

19 days ago

GLP-1 race evolves as Amgen & weight-loss pills enter the scene

Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

Barrons.com

19 days ago

Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street

Fortune

19 days ago

All bark, no bite: Trump’s latest trade war turns into another TACO salad for Wall Street

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More

Barrons.com

19 days ago

These Stocks Moved the Most Today: Eli Lilly, Electronic Arts, Intel, GlobalFoundries, Boeing, AppLovin, Costco, and More

MT Newswires

19 days ago

Sector Update: Health Care Stocks Gain Late Afternoon

MT Newswires

19 days ago

Sector Update: Health Care Stocks Rise Friday Afternoon

MT Newswires

19 days ago

US Equity Indexes Rise as Investors Assess Latest Inflation Data

MT Newswires

19 days ago

Sector Update: Health Care

MT Newswires

19 days ago

US Equity Indexes Rise in Midday Trading

ACCESS Newswire

19 days ago

CASI Pharmaceuticals Appoints James Huang to Board of Directors

MT Newswires

19 days ago

Amgen to Invest $650 Million in Expanding US Manufacturing Network

AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS

PR Newswire

19 days ago

AMGEN ANNOUNCES $650M EXPANSION OF U.S. MANUFACTURING, CREATING HUNDREDS OF NEW JOBS

Eli Lilly, Pfizer Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

Barrons.com

19 days ago

Eli Lilly, Pfizer Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.

US, European pharma stocks steady after Trump's tariff move, Asia slips

Reuters

20 days ago

US, European pharma stocks steady after Trump's tariff move, Asia slips

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?

Insider Monkey

20 days ago

Is Amgen (AMGN) a Safe Bet for Income Investors in Cheap Quarterly Dividend Stocks?

Dr. Robert Lenz Joins Unlearn as Strategic Advisor

Business Wire

20 days ago

Dr. Robert Lenz Joins Unlearn as Strategic Advisor

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

Zacks

21 days ago

Amgen (AMGN) Dips More Than Broader Market: What You Should Know

MT Newswires

21 days ago

Citigroup Adjusts Price Target on Amgen to $315 From $310, Maintains Neutral Rating

Pharma’s next generation of blockbuster antibodies takes a ‘more is better’ approach

Pharma Voice

21 days ago

Pharma’s next generation of blockbuster antibodies takes a ‘more is better’ approach

A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)

Motley Fool

21 days ago

A Once-in-a-Decade Opportunity: 10 Billion Reasons to Pay Attention to This Monster Quantum Computing Company (Hint: Not IonQ)

Amgen (NASDAQ:AMGN) jumps 4.2% this week, though earnings growth is still tracking behind three-year shareholder returns

Simply Wall St.

22 days ago

Amgen (NASDAQ:AMGN) jumps 4.2% this week, though earnings growth is still tracking behind three-year shareholder returns

Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?

Zacks

23 days ago

Amgen (AMGN) Moves 3.5% Higher: Will This Strength Last?

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors

Business Wire

23 days ago

Cellares Appoints Former Kite Global Ops Leader, Christopher McDonald, to Board of Advisors

Why Amgen (AMGN) Stock Is Trading Up Today

StockStory

a month ago

Why Amgen (AMGN) Stock Is Trading Up Today

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care Stocks Mixed Friday Afternoon

MT Newswires

a month ago

Sector Update: Health Care

EMA Backs Amgen Drug For Rare Autoimmune Disorder

Benzinga

a month ago

EMA Backs Amgen Drug For Rare Autoimmune Disorder

MT Newswires

a month ago

Amgen's Uplizna Receives European Human Medicines Committee Recommendation for IgG4-Related Disease

MT Newswires

a month ago

Organon, Shanghai Henlius Say EU Approves Denosumab Biosimilars

J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why

Zacks

a month ago

J&J Expects Innovative Medicines Growth Despite Stelara LOE: Here's Why

MT Newswires

a month ago

Alnylam Joins Alliance for Genomic Discovery

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Zacks

a month ago

Why Amgen (AMGN) is a Top Value Stock for the Long-Term

Ollin debuts with $100M and plans to challenge top-selling eye drugs

BioPharma Dive

a month ago

Ollin debuts with $100M and plans to challenge top-selling eye drugs

What Do Analysts Think About Amgen Inc. (AMGN)?

Insider Monkey

a month ago

What Do Analysts Think About Amgen Inc. (AMGN)?

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?

Zacks

a month ago

AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?

Amgen Insiders Sold US$12m Of Shares Suggesting Hesitancy

Simply Wall St.

a month ago

Amgen Insiders Sold US$12m Of Shares Suggesting Hesitancy

Stock Market Today: Dow Wavers Amid Surprise Retail Sales; Dave & Busters Plunges (Live Coverage)

Investor's Business Daily

a month ago

Stock Market Today: Dow Wavers Amid Surprise Retail Sales; Dave & Busters Plunges (Live Coverage)

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board

GlobeNewswire

a month ago

Immuneering Appoints Dr. Thomas Schall as Chairman of the Board

Why California’s biopharma boom is critical for logistics

FreightWaves

a month ago

Why California’s biopharma boom is critical for logistics

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

a month ago

Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It

Samsung Biologics, Amgen and Biocon invest in US pharma sites

Manufacturing Dive

a month ago

Samsung Biologics, Amgen and Biocon invest in US pharma sites

2 Healthcare Dividend Stocks to Buy and Hold

Motley Fool

a month ago

2 Healthcare Dividend Stocks to Buy and Hold

Guggenheim Maintains a Hold on Amgen Inc. (AMGN)

Insider Monkey

a month ago

Guggenheim Maintains a Hold on Amgen Inc. (AMGN)

Morningstar Research

a month ago

Morningstar | A Weekly Summary of Stock Ideas and Developments in the Companies We Cover

Argus Research

a month ago

Analyst Report: AMGEN Inc.

Argus Research

a month ago

Market Digest: AMGN, APD, PCG, RL, SJM, DG

Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab

Insider Monkey

a month ago

Amgen Inc (AMGN) Releases Top-Line Results From ASCEND Study of Rocatinlimab

Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study

Simply Wall St.

a month ago

Amgen (AMGN) And Kyowa Kirin Reveal Initial Results From Rocatinlimab ASCEND Study

Prevent Blindness Kicks Off Annual World Sight Day Activities to Raise Awareness, Provide Education on the Importance of Vision Health and Equitable Access to Eye Care

PR Newswire

a month ago

Prevent Blindness Kicks Off Annual World Sight Day Activities to Raise Awareness, Provide Education on the Importance of Vision Health and Equitable Access to Eye Care

Share on Social Networks: